Eritel LN 40 Tablets are a combination medication containing Telmisartan 40 mg and Cilnidipine 10 mg. This dual-action formulation is commonly prescribed as part of a comprehensive approach to managing blood pressure and supporting cardiovascular health under medical supervision.
Telmisartan belongs to the class of angiotensin II receptor blockers (ARBs). It works by blocking the effects of angiotensin II, a natural substance that causes blood vessels to constrict. By inhibiting this action, Telmisartan helps relax blood vessels, allowing for smoother blood flow and reduced resistance in the arteries.
Cilnidipine is a calcium channel blocker that acts on both L-type and N-type calcium channels. It helps relax and widen blood vessels by reducing calcium influx into vascular smooth muscle cells. Additionally, its action on N-type calcium channels may contribute to reduced sympathetic nerve activity, which can further support blood pressure regulation.
The combination of Telmisartan and Cilnidipine in Eritel LN 40 Tablets offers a complementary mechanism of action. While Telmisartan targets hormonal pathways affecting blood vessel constriction, Cilnidipine directly relaxes vascular muscles and may help regulate nerve-mediated vascular tone. This dual mechanism can provide enhanced support for individuals requiring combination therapy.
Eritel LN 40 Tablets are typically taken once daily or as directed by a healthcare professional. The tablet should be swallowed whole with water and can be taken with or without food. Consistency in timing is recommended to maintain stable levels of the medication in the body.
This medication is usually prescribed as part of a broader management plan that may include lifestyle changes such as a balanced diet, reduced salt intake, regular exercise, and stress management. These measures can complement the effects of the medication and contribute to overall cardiovascular health.
Eritel LN 40 Tablets should only be used under the supervision of a qualified healthcare provider. Patients are advised to follow the prescribed dosage and not to discontinue use abruptly without consulting their doctor. Regular monitoring of blood pressure and general health may be recommended during treatment.
Individuals with pre-existing conditions such as kidney or liver disorders, heart conditions, or those taking other medications should inform their healthcare provider before starting this medication. This helps ensure safe and effective use while minimizing the risk of interactions.
The product is manufactured under strict quality standards to ensure consistency, safety, and effectiveness. The packaging is designed to protect the tablets from moisture and environmental exposure, maintaining their stability.
When used responsibly and as directed, Eritel LN 40 Tablets can be an effective option for supporting blood pressure management and cardiovascular health. Combining medication use with healthy lifestyle practices is essential for achieving optimal results.